CAS: 3847-29-8; Erythromycin Lactobionate (200 Mg)

该化合物是来自血清细胞细胞细胞的大型抗生素,主要用于治疗各种细菌感染,特别是克菌阳性细菌和某些克菌阴性生物的感染,其特点是其乳胶生物盐形式,它增加了水溶性,适合静脉注射;乙酰乙型乙酰丙酰乙酰菌菌,它具有广泛的活动范围,可以防止呼吸道感染,皮肤感染和某些性传播疾病;其行动机制包括禁止细菌蛋白质合成,它与50-S核子元素结合,从而防止细菌的生长和繁殖;该化合物一般具有良好的发芽性,尽管它可能会造成胃肠侧效应,并有可能与其他药物发生相互作用,因为其对肝酶有影响.同所有抗生酶一样,适当使用抗生炎剂对于防止抗生阻力的发展至关重要.

结构式图片

上下游产品

CAS号114-07-8 红霉素 | CAS号96-82-2 乳糖酸

合成工艺路线路线简述

    红霉素,乳糖酸置于水体系中,用99%的收率获得产物乳糖酸红霉素
    参考文献:Hydrates Of Erythromycin Salts,The Preparation And The Use Thereof
    标题:Hydrates Of Erythromycin Salts,The Preparation And The Use Thereof

    海关参考信息

    专利信息


    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    专利号:US-2006074032-A1
    优先权日:2000-11-29
    标题 :Synthesis and separation of optically active isomers of erythromycin and their biological actions
    发明人:SOMBERG JOHN; RANADE VASANT
    权利人:ACADEMIC PHARM INC
    摘要:The present invention provides methods for purifying and using optically active isomers of erythromycin as well as compositions comprising such optically active isomers. Such optically active isomers having desired actions as an antibiotic substantially separable from undesirable effects on GI motility and the cardiac potassium channels such that the cardiac action potential is not prolonged and the QT interval on the surface EKG (electrocardiogram) is not increased, such that the erythromycin can be useful for more effective therapy of systemic infections. Also disclosed are methods for assaying the levels of such isomers present in the biological fluids.

    专利号:WO-0026406-A1
    优先权日:1998-11-04
    标题:METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs
    发明人:HASEL KARL W; HILBUSH BRIAN S
    权利人:DIGITAL GENE TECH INC
    摘要:An improved method for the simultaneous sequence-specific identification of mRNAs in a mRNA population allows the visualization of nearly every mRNA expressed by a tissue as a distinct band on a gel whose intensity corresponds roughly to the concentration of the mRNA. In general, the method comprises the formation of cDNA using anchor primers to fix a 3'-endpoint, producing cloned inserts from the cDNA in a vector containing a bacteriophage-specific promoter for subsequent RNA synthesis, generating linearized fragments of the cloned inserts, preparing cRNA, transcribing cDNA from the cRNA and performing two sequence specific PCR amplifications of the cDNA. In preferred embodiments, the method comprises comparing the length and at least part of the nucleotide sequence of the PCR products to expected values determined from a database of nucleotide sequences. The method can identify changes in expression of mRNA associated with the administration of drugs or with physiological or pathological conditions. Also provided are vectors and primers useful for the practice of the improved method.

    专利号:JP-2008527092-A
    优先权日:2005-01-04
    标 题 :Synthesis of hybrid block copolymers and their use
    哈药集团制药总厂
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hayao.com
    电话: 0451-86671777👤
    📞哈药集团制药总厂 ⚠️参考联系方式

    销售电话:0451-86671777
    邮箱:webadmin@hayaozong.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    海南海灵化学制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hailingpharm.com
    电话: 0898-68639900👤
    📞海南海灵化学制药有限公司 ⚠️参考联系方式

    销售电话:0898-68639900
    邮箱:webmaster@hailingpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北恒硕化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hengshuochem.com
    企业联系电话:027-82200625;82830253👤
    📞湖北恒硕化工有限公司 ⚠️参考联系方式
    联系人:王硕 徐文琪
    电话:027-82200625;82830253
    手机:13986271535;13995541600
    传真:027-82830253
    邮箱:hengshuochem@163.com
    通信地址: 湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    邮编: 430014
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Arzneimittel-Forschung. Drug Research., 20(1751), 1970 []
    参考文献:10.2165/00002018-199615010-00007
    摘要:George DK, Crawford DH. Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Saf. 1996 Jul;15(1):79–85. doi: 10.2165/00002018-199615010-00007.
    参考文献:10.1007/s00534-011-0393-6
    摘要:Okano K, Kakinoki K, Suto H, Oshima M, Kashiwagi H, Yamamoto N, Akamoto S, Fujiwara M, Takama T, Usuki H, Hagiike M, Suzuki Y. Persisting ratio of total amylase output in drain fluid can predict postoperative clinical pancreatic fistula. J Hepatobiliary Pancreat Sci. 2011 Nov;18(6):815–20. doi: 10.1007/s00534-011-0393-6.
    参考文献:10.2165/00003495-199447010-00004
    摘要:Napolitano C, Priori SG, Schwartz PJ. Torsade de pointes. Mechanisms and management. Drugs. 1994 Jan;47(1):51–65. doi: 10.2165/00003495-199447010-00004.
    参考文献:10.1007/s00595-007-3662-x
    摘要:Kamoda Y, Fujino Y, Matsumoto I, Shinzeki M, Sakai T, Kuroda Y. Usefulness of performing a pancreaticojejunostomy with an internal stent after a pancreatoduodenectomy. Surg Today. 2008;38(6):524–8. doi: 10.1007/s00595-007-3662-x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知